These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 34855252)
1. Value of cemiplimab in progressive metastatic cutaneous squamous cell carcinoma after kidney transplantation: a case report. Geidel G; Rünger A; Schneider SW; Gebhardt C J Eur Acad Dermatol Venereol; 2022 Jan; 36 Suppl 1():49-52. PubMed ID: 34855252 [TBL] [Abstract][Full Text] [Related]
2. A Pilot Study of Checkpoint Inhibitors in Solid Organ Transplant Recipients with Metastatic Cutaneous Squamous Cell Carcinoma. Tsung I; Worden FP; Fontana RJ Oncologist; 2021 Feb; 26(2):133-138. PubMed ID: 32969143 [TBL] [Abstract][Full Text] [Related]
4. Cemiplimab for advanced cutaneous squamous cell carcinoma in kidney transplant recipients. Van Meerhaeghe T; Baurain JF; Bechter O; Orte Cano C; Del Marmol V; Devresse A; Doubel P; Hanssens M; Hellemans R; Lienard D; Rutten A; Sprangers B; Le Moine A; Aspeslagh S Front Nephrol; 2022; 2():1041819. PubMed ID: 37675002 [TBL] [Abstract][Full Text] [Related]
5. Safe Administration of Cemiplimab to a Kidney Transplant Patient with Locally Advanced Squamous Cell Carcinoma of the Scalp. Paoluzzi L; Ow TJ Curr Oncol; 2021 Jan; 28(1):574-580. PubMed ID: 33477979 [TBL] [Abstract][Full Text] [Related]
6. Cemiplimab for Locally Advanced Cutaneous Squamous Cell Carcinoma: A Case Series of 3 Unique Scenarios. Akhtar K; Sravanthi MV; D'Angelo J; Sivapiragasam A J Investig Med High Impact Case Rep; 2022; 10():23247096221121408. PubMed ID: 36017984 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of Cemiplimab as Adjuvant or Neoadjuvant Therapy in the Treatment of Cutaneous Squamous Cell Carcinoma. Hiller A; Oxford M; Kulkarni P; Fornadley J; Lo A; Sivik J; Drabick J; Vakharia K Ann Plast Surg; 2024 Apr; 92(4S Suppl 2):S129-S131. PubMed ID: 38556660 [TBL] [Abstract][Full Text] [Related]
8. Prompt response of advanced cutaneous squamous cell carcinoma to cemiplimab in a kidney transplant patient receiving treatment with everolimus. Gambichler T; Hessam S; Lüttringhaus T; Boms S Clin Exp Dermatol; 2022 Mar; 47(3):608-609. PubMed ID: 34767651 [TBL] [Abstract][Full Text] [Related]
9. Advanced cutaneous squamous cell carcinoma of the head in two renal transplanted patients treated with cemiplimab. Orte Cano C; Van Meerhaeghe T; Tannous J; Lienard D; Van Gestel D; Cuylits N; Luce S; Carlot S; Le Moine A; Aspeslagh S; Del Marmol V J Eur Acad Dermatol Venereol; 2022 Jan; 36 Suppl 1():53-58. PubMed ID: 34855244 [TBL] [Abstract][Full Text] [Related]
10. Cemiplimab for locally advanced cutaneous squamous cell carcinoma: safety, efficacy, and position in therapy panel. Lebas E; Marchal N; Rorive A; Nikkels AF Expert Rev Anticancer Ther; 2021 Apr; 21(4):355-363. PubMed ID: 33554680 [TBL] [Abstract][Full Text] [Related]
11. Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma. Baggi A; Quaglino P; Rubatto M; Depenni R; Guida M; Ascierto PA; Trojaniello C; Queirolo P; Saponara M; Peris K; Spagnolo F; Bianchi L; De Galitiis F; Potenza MC; Proietti I; Marconcini R; Botticelli A; Barbieri V; Licitra L; Alfieri S; Ficorella C; Cortellini A; Fargnoli MC; Troiani T; Tondulli L; Bossi P Eur J Cancer; 2021 Nov; 157():250-258. PubMed ID: 34536948 [TBL] [Abstract][Full Text] [Related]
12. Infrequent liver injury from cemiplimab in patients with advanced cutaneous squamous cell carcinoma. Swanson L; Kassab I; Tsung I; Worden FP; Fontana RJ Immunotherapy; 2022 Apr; 14(6):409-418. PubMed ID: 35232282 [TBL] [Abstract][Full Text] [Related]
13. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment. Stratigos AJ; Garbe C; Dessinioti C; Lebbe C; Bataille V; Bastholt L; Dreno B; Concetta Fargnoli M; Forsea AM; Frenard C; Harwood CA; Hauschild A; Hoeller C; Kandolf-Sekulovic L; Kaufmann R; Kelleners-Smeets NWJ; Malvehy J; Del Marmol V; Middleton MR; Moreno-Ramirez D; Pellecani G; Peris K; Saiag P; van den Beuken-van Everdingen MHJ; Vieira R; Zalaudek I; Eggermont AMM; Grob JJ; Eur J Cancer; 2020 Mar; 128():83-102. PubMed ID: 32113942 [TBL] [Abstract][Full Text] [Related]
14. Cemiplimab in cutaneous squamous cell carcinomas (SCC): an overview and a clinical case. Ghidini A; Santangelo D; Vaccaro G; Chillura M; Petrelli F Oral Oncol; 2022 May; 128():105847. PubMed ID: 35367788 [TBL] [Abstract][Full Text] [Related]